Aureostem Research supports access across a broad and evolving range of therapeutic areas, shaped by regional healthcare priorities, epidemiological trends, and the capabilities of our accredited manufacturing partners. Our therapeutic focus is intentionally flexible, allowing us to expand into new segments as markets evolve and as additional partners join our global network.
Current areas of support include:
- Anti‑Infectives
Solutions addressing bacterial, viral, fungal, and parasitic infections — a core need across emerging and high‑growth markets.
- Cardiovascular Health
Therapies supporting hypertension, dyslipidemia, heart failure, and other cardiovascular conditions.
- Central Nervous System (CNS)
Products for neurological and psychiatric conditions including epilepsy, depression, anxiety, neuropathic pain, and neurodegenerative disorders.
- Gastrointestinal & Hepatology
Treatments for acid‑peptic disorders, IBS, IBD, liver diseases, and digestive health.
- Endocrine & Metabolic Disorders
Solutions for diabetes, thyroid disorders, metabolic syndrome, and related endocrine conditions.
- Respiratory Care
Therapies for asthma, COPD, allergic conditions, and respiratory infections.
- Oncology & Immunology
Select oncology and immunology products supported where regional regulatory pathways and partner capabilities allow.
- Women’s Health
Products supporting reproductive health, hormonal balance, maternal care, and gynecological conditions.
- Pain Management & Musculoskeletal Care
Acute and chronic pain therapies, anti‑inflammatory agents, and musculoskeletal support solutions.
- Dermatology & Regenerative Care
Pharmaceutical dermatology, wound care, and regenerative solutions including autologous growth‑factor technologies.
- Nutraceuticals & Preventive Health
Evidence‑based nutraceuticals supporting immunity, metabolic health, cognitive function, and general wellness.
- Veterinary Health
Pharmaceutical and nutritional solutions supporting animal health across companion and livestock segments.